This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1996 May 25;347(9013):1420-1.

doi: 10.1016/s0140-6736(96)91675-x.

Fludarabine in chronic leukaemia

A B Astrow¹

Affiliations

PMID: 8676619
DOI: 10.1016/s0140-6736(96)91675-x

Clinical Trial

Fludarabine in chronic leukaemia

A B Astrow. Lancet. 1996.

. 1996 May 25;347(9013):1420-1.

doi: 10.1016/s0140-6736(96)91675-x.

Author

A B Astrow¹

Affiliation

¹ Department of Medicine, Saint Vincent's Hospital and Medical Center of New York, NY, USA.

PMID: 8676619
DOI: 10.1016/s0140-6736(96)91675-x

No abstract available

PubMed Disclaimer

Comment on

Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL.
Johnson S, Smith AG, Löffler H, Osby E, Juliusson G, Emmerich B, Wyld PJ, Hiddemann W. Johnson S, et al. Lancet. 1996 May 25;347(9013):1432-8. doi: 10.1016/s0140-6736(96)91681-5. Lancet. 1996. PMID: 8676625 Clinical Trial.

Publication types

Actions
Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.